Literature DB >> 31425681

Construction of 3D in vitro models by bioprinting human pluripotent stem cells: Challenges and opportunities.

Federico Salaris1, Alessandro Rosa2.   

Abstract

Three-dimensional (3D) printing of biological material, or 3D bioprinting, is a rapidly expanding field with interesting applications in tissue engineering and regenerative medicine. Bioprinters use cells and biocompatible materials as an ink (bioink) to build 3D structures representative of organs and tissues, in a controlled manner and with micrometric resolution. Human embryonic (hESCs) and induced (hiPSCs) pluripotent stem cells are ideally able to provide all cell types found in the human body. A limited, but growing, number of recent reports suggest that cells derived by differentiation of hESCs and hiPSCs can be used as building blocks in bioprinted human 3D models, reproducing the cellular variety and cytoarchitecture of real tissues. In this review we will illustrate these examples, which include hepatic, cardiac, vascular, corneal and cartilage tissues, and discuss challenges and opportunities of bioprinting more demanding cell types, such as neurons, obtained from human pluripotent stem cells.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  3D; Bioink; Bioprinting; Embryonic stem cells; Induced Pluripotent Stem Cells; Organoid

Mesh:

Year:  2019        PMID: 31425681     DOI: 10.1016/j.brainres.2019.146393

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Transforming a well into a chip: A modular 3D-printed microfluidic chip.

Authors:  Rossana Rauti; Adi Ess; Baptiste Le Roi; Yevgeniy Kreinin; Mark Epshtein; Netanel Korin; Ben M Maoz
Journal:  APL Bioeng       Date:  2021-04-28

Review 2.  hiPSCs for predictive modelling of neurodegenerative diseases: dreaming the possible.

Authors:  Pia Rivetti di Val Cervo; Dario Besusso; Paola Conforti; Elena Cattaneo
Journal:  Nat Rev Neurol       Date:  2021-03-03       Impact factor: 42.937

Review 3.  Applications of 3D Bioprinting Technology in Induced Pluripotent Stem Cells-Based Tissue Engineering.

Authors:  Arvind Kumar Shukla; Ge Gao; Byoung Soo Kim
Journal:  Micromachines (Basel)       Date:  2022-01-20       Impact factor: 2.891

Review 4.  Cutting-Edge Technologies for Inflamed Joints on Chip: How Close Are We?

Authors:  Emine Kahraman; Ricardo Ribeiro; Meriem Lamghari; Estrela Neto
Journal:  Front Immunol       Date:  2022-03-10       Impact factor: 7.561

Review 5.  Bioengineering platforms for cell therapeutics derived from pluripotent and direct reprogramming.

Authors:  Yoonhee Jin; Seung-Woo Cho
Journal:  APL Bioeng       Date:  2021-07-06

6.  METTL1-mediated m7G methylation maintains pluripotency in human stem cells and limits mesoderm differentiation and vascular development.

Authors:  Yujie Deng; Zhongyang Zhou; Weidong Ji; Shuibin Lin; Min Wang
Journal:  Stem Cell Res Ther       Date:  2020-07-22       Impact factor: 6.832

Review 7.  Perspectives on 3D Bioprinting of Peripheral Nerve Conduits.

Authors:  Soja Saghar Soman; Sanjairaj Vijayavenkataraman
Journal:  Int J Mol Sci       Date:  2020-08-12       Impact factor: 5.923

8.  3D Bioprinted Human Cortical Neural Constructs Derived from Induced Pluripotent Stem Cells.

Authors:  Federico Salaris; Cristina Colosi; Carlo Brighi; Alessandro Soloperto; Valeria de Turris; Maria Cristina Benedetti; Silvia Ghirga; Maria Rosito; Silvia Di Angelantonio; Alessandro Rosa
Journal:  J Clin Med       Date:  2019-10-02       Impact factor: 4.241

9.  Analysis of human brain by magnetic resonance imaging using content-based image retrieval.

Authors:  Qaim Mehdi Rizvi
Journal:  Int J Health Sci (Qassim)       Date:  2020 Mar-Apr

Review 10.  Small extracellular vesicles from menstrual blood-derived mesenchymal stem cells (MenSCs) as a novel therapeutic impetus in regenerative medicine.

Authors:  Lijun Chen; Jingjing Qu; Quanhui Mei; Xin Chen; Yangxin Fang; Lu Chen; Yifei Li; Charlie Xiang
Journal:  Stem Cell Res Ther       Date:  2021-08-03       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.